Targeting epigenetic regulators to overcome drug resistance in cancers

N Wang, T Ma, B Yu - Signal transduction and targeted therapy, 2023 - nature.com
Drug resistance is mainly responsible for cancer recurrence and poor prognosis. Epigenetic
regulation is a heritable change in gene expressions independent of nucleotide sequence …

Small cell lung cancer transformation: From pathogenesis to treatment

X Yin, Y Li, H Wang, T Jia, E Wang, Y Luo, Y Wei… - seminars in Cancer …, 2022 - Elsevier
Small cell lung cancer (SCLC) is a type of neuroendocrine tumor with high malignancy and
poor prognosis. Besides the de novo SCLC, there is transformed SCLC, which has similar …

The mechanism of DNA methylation and miRNA in breast cancer

L Ma, C Li, H Yin, J Huang, S Yu, J Zhao… - International Journal of …, 2023 - mdpi.com
Breast cancer is the most prevalent cancer in the world. Currently, the main treatments for
breast cancer are radiotherapy, chemotherapy, targeted therapy and surgery. The treatment …

Recent progress of biosensors for the detection of lung cancer markers

S Chen, M Li, T Weng, D Wang, J Geng - Journal of Materials …, 2023 - pubs.rsc.org
Lung cancer is one of the most common cancers worldwide and the leading cause of death.
Early screening of lung cancer is exceptionally essential for later treatment. Abnormal lung …

Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration

J Zhu, R Huang, R Yang, Y Xiao, J Yan, C Zheng… - Cancer cell …, 2021 - Springer
Background Targeting tumor microenvironment (TME) may provide therapeutic activity and
selectivity in treating cancers. Therefore, an improved understanding of the mechanism by …

[HTML][HTML] Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer

H Luo, J Shan, H Zhang, G Song, Q Li, CX Xu - Seminars in Cancer Biology, 2022 - Elsevier
Dysregulation of the epigenetic processes, such as DNA methylation, histone modifications,
and modulation of chromatin states, drives aberrant transcription that promotes initiation and …

[PDF][PDF] Advances in Targeted Therapy Against Driver Mutations and Epigenetic Alterations in Non-Small Cell Lung Cancer.

J Shi, Y Chen, C Peng, L Kuang, Z Zhang… - … (Tech Science Press), 2022 - researchgate.net
The incidence and mortality of lung cancer rank top three of all cancers worldwide.
Accounting for 85% of the total number of lung cancer, non-small cell lung cancer (NSCLC) …

HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism

J Cui, F Xu, W Bai, T Zhao, J Hong, W Zuo - Journal of Translational …, 2023 - Springer
Background Histone deacetylases (HDAC) contribute to oncogenic program, pointing to
their inhibitors as a potential strategy against cancers. We, thus, studied the mechanism of …

Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease Biomarkers

M Agostini, P Traldi, M Hamdan - Medicina, 2023 - mdpi.com
Mass spectrometry-based proteomics is a key player in research efforts to characterize
aberrant epigenetic alterations, including histone post-translational modifications and DNA …

Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance

N Zhao, C Lai, Y Wang, S Dai, H Gu - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Colorectal cancer (CRC) is one of the deadliest malignancies worldwide, ranking third in
incidence and second in mortality. Remarkably, early stage localized CRC has a 5-year …